Ginkgo Bioworks Holdings (DNA) Times Interest Earned (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Times Interest Earned of -$24.27 for Q1 2026, down 28714.87% on a QoQ basis from -$0.08 in Q4 2025, and up 18.57% year-over-year from -$20.47 in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Times Interest Earned (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$24.27 for Q1 2026.
- Quarterly Times Interest Earned rose 18.57% year-over-year to -$24.27 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$101.22 (up 40.57% YoY) and the FY2025 annual result came in at -$0.38, up 48.25% from the prior year.
- Times Interest Earned was -$24.27 for Q1 2026 at Ginkgo Bioworks Holdings, down from -$0.08 in the prior quarter.
- Across five years, Times Interest Earned topped out at $21.62 in Q2 2024 and bottomed at -$30.21 in Q3 2025.
- A 5-year average of -$6.64 and a median of -$4.84 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned tumbled 16165.5% — and 2024, when it jumped 546.69%.
- Ginkgo Bioworks Holdings' Times Interest Earned stood at -$0.28 in 2022, then tumbled by 630.68% to -$2.02 in 2023, then slumped by 63.11% to -$3.3 in 2024, then jumped by 97.45% to -$0.08 in 2025, then plunged by 28714.87% to -$24.27 in 2026.
- Business Quant data shows DNA's Times Interest Earned at -$24.27 in Q1 2026, -$0.08 in Q4 2025, and -$30.21 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | -24.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.27 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -30.21 |
| Jun 30, 2025 | -22.02 |
| Mar 31, 2025 | -29.80 |
| Dec 31, 2024 | -3.30 |
| Sep 30, 2024 | 5.97 |
| Jun 30, 2024 | 21.62 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | -2.02 |
| Sep 30, 2023 | 19.07 |
| Jun 30, 2023 | -4.84 |
| Mar 31, 2023 | -5.70 |
| Dec 31, 2022 | -0.28 |
| Sep 30, 2022 | -12.87 |
| Jun 30, 2022 | -14.81 |
| Mar 31, 2022 | -9.07 |
| Dec 31, 2021 | -3,057.60 |
| Sep 30, 2021 | -0.08 |
| Dec 31, 2020 | -94.73 |